A company flogging ‘cancer cure’ and male fertility ‘enhancing’ s...
A company flogging “cancer cure” and male fertility “enhancing” supplements online, in catalogs and via infomercials violated a 2000 FTC order that it present “competent” scientific evidence for product claims, the FTC said. The Commission filed civil contempt charges…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
in U.S. Dist. Court, Newark, against Lane Labs and principals Andrew and William Lane, alleging the company made unsubstantiated claims that products BeneFin and SkinAnswer could cure, treat and prevent cancer. Lane Labs based claims that FertilMale improved male fertility on “flawed” data, the FTC said.